Fidaxomicin versus Vancomycin in the Treatment of Clostridium difficile Infection: Canadian Outcomes

about

Antibiotic treatment for Clostridium difficile-associated diarrhoea in adults.Molecular epidemiology and antimicrobial susceptibility of human Clostridium difficile isolates from a single institution in Northern China.

P2860

Q30235446-72BDA5FD-7FB5-40B1-BFD6-314DFD4AFACD Q55430134-459EDC45-DE13-4BA3-829E-819CB1550795

P2860

Fidaxomicin versus Vancomycin in the Treatment of Clostridium difficile Infection: Canadian Outcomes

Item

http://www.wikidata.org/entity/Q36996876

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Fidaxomicin versus Vancomycin ...... e Infection: Canadian Outcomes

@en

type

Item

label

Fidaxomicin versus Vancomycin ...... e Infection: Canadian Outcomes

@en

prefLabel

Fidaxomicin versus Vancomycin ...... e Infection: Canadian Outcomes

@en

P1476

Fidaxomicin versus Vancomycin ...... e Infection: Canadian Outcomes

@en

P2093

Christine Lee

http://www.w3.org/2001/XMLSchema#string

Karl Weiss

http://www.w3.org/2001/XMLSchema#string

Marvin Gerson

http://www.w3.org/2001/XMLSchema#string

Sherwood L Gorbach

http://www.w3.org/2001/XMLSchema#string

Thomas J Louie

http://www.w3.org/2001/XMLSchema#string

Wendy Arnott

http://www.w3.org/2001/XMLSchema#string

P2860

Risk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic review

A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease

Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole.

Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA).

Fidaxomicin versus vancomycin for Clostridium difficile infection.

Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections.

A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.

Efficacy of fidaxomicin versus vancomycin as therapy for Clostridium difficile infection in individuals taking concomitant antibiotics for other concurrent infections

Killing kinetics of fidaxomicin and its major metabolite, OP-1118, against Clostridium difficile.

Hypervirulent Clostridium difficile strains in hospitalized patients, Canada

P304

8048757

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2016/8048757

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

2016

http://www.w3.org/2001/XMLSchema#string

P50

Louis Valiquette

P577

2016-05-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27366179

http://www.w3.org/2001/XMLSchema#string

P921

Clostridium difficile

P932

4904592

http://www.w3.org/2001/XMLSchema#string

Fidaxomicin versus Vancomycin in the Treatment of Clostridium difficile Infection: Canadian Outcomes

about

P2860

P2860

Fidaxomicin versus Vancomycin in the Treatment of Clostridium difficile Infection: Canadian Outcomes

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P921

P932